132 related articles for article (PubMed ID: 28026162)
21. Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1.
Gambini L; Udompholkul P; Baggio C; Muralidharan A; Kenjić N; Assar Z; Perry JJP; Pellecchia M
J Med Chem; 2021 Apr; 64(8):4903-4912. PubMed ID: 33797903
[TBL] [Abstract][Full Text] [Related]
22. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
[TBL] [Abstract][Full Text] [Related]
23. N-locking stabilization of covalent helical peptides: Application to Bfl-1 antagonists.
Baggio C; Udompholkul P; Gambini L; Jossart J; Salem AF; Håkansson M; Perry JJP; Pellecchia M
Chem Biol Drug Des; 2020 Apr; 95(4):412-426. PubMed ID: 31898401
[TBL] [Abstract][Full Text] [Related]
24. Molecular Dynamics model of peptide-protein conjugation: case study of covalent complex between Sos1 peptide and N-terminal SH3 domain from Grb2.
Luzik DA; Rogacheva ON; Izmailov SA; Indeykina MI; Kononikhin AS; Skrynnikov NR
Sci Rep; 2019 Dec; 9(1):20219. PubMed ID: 31882608
[TBL] [Abstract][Full Text] [Related]
25. Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy.
Baggio C; Udompholkul P; Gambini L; Salem AF; Jossart J; Perry JJP; Pellecchia M
J Med Chem; 2019 Oct; 62(20):9188-9200. PubMed ID: 31550155
[TBL] [Abstract][Full Text] [Related]
26. Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues.
Gambini L; Baggio C; Udompholkul P; Jossart J; Salem AF; Perry JJP; Pellecchia M
J Med Chem; 2019 Jun; 62(11):5616-5627. PubMed ID: 31095386
[TBL] [Abstract][Full Text] [Related]
27.
Fletcher JM; Horner KA; Bartlett GJ; Rhys GG; Wilson AJ; Woolfson DN
Chem Sci; 2018 Oct; 9(39):7656-7665. PubMed ID: 30393526
[TBL] [Abstract][Full Text] [Related]
28. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer.
Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD
Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201
[TBL] [Abstract][Full Text] [Related]
29. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.
Lionnard L; Duc P; Brennan MS; Kueh AJ; Pal M; Guardia F; Mojsa B; Damiano MA; Mora S; Lassot I; Ravichandran R; Cochet C; Aouacheria A; Potts PR; Herold MJ; Desagher S; Kucharczak J
Cell Death Differ; 2019 May; 26(5):902-917. PubMed ID: 30042493
[TBL] [Abstract][Full Text] [Related]
30. Progress in targeting the BCL-2 family of proteins.
Garner TP; Lopez A; Reyna DE; Spitz AZ; Gavathiotis E
Curr Opin Chem Biol; 2017 Aug; 39():133-142. PubMed ID: 28735187
[TBL] [Abstract][Full Text] [Related]
31. Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1.
Jenson JM; Ryan JA; Grant RA; Letai A; Keating AE
Elife; 2017 Jun; 6():. PubMed ID: 28594323
[TBL] [Abstract][Full Text] [Related]
32. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
[TBL] [Abstract][Full Text] [Related]
33. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
Huhn AJ; Guerra RM; Harvey EP; Bird GH; Walensky LD
Cell Chem Biol; 2016 Sep; 23(9):1123-1134. PubMed ID: 27617850
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy.
Li X; Dou J; You Q; Jiang Z
Eur J Med Chem; 2021 Aug; 220():113539. PubMed ID: 34034128
[TBL] [Abstract][Full Text] [Related]
35. Last but not least: BFL-1 as an emerging target for anti-cancer therapies.
Wang G; Diepstraten ST; Herold MJ
Biochem Soc Trans; 2022 Aug; 50(4):1119-1128. PubMed ID: 35900226
[TBL] [Abstract][Full Text] [Related]
36. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
[TBL] [Abstract][Full Text] [Related]
37. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
